Biotech · Private company
Viralytics
Track this companyFree. Adds Viralytics to your Dealase workspace and tells you when its record changes.
Clinical trials60 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Coxsackievirus A21 (CVA21)Phase 2 · Malignant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- CVA21Phase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- CAVATAKPhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- CVA21Phase 1 · Uveal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- CVA21/pembrolizumabPhase 1 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- IpilimumabPhase 1 · Uveal MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 1 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER)PHASE1 · COMPLETED · started Jan 29, 2018ClinicalTrials.gov NCT03408587 · fetched Nov 12, 2026
- Intratumoral CAVATAK (CVA21) and Pembrolizumab in Patients With Advanced Melanoma (VLA-011 CAPRA)PHASE1 · COMPLETED · started Dec 17, 2015ClinicalTrials.gov NCT02565992 · fetched Nov 12, 2026
- Intratumoral CAVATAK (CVA21) and Ipilimumab in Patients With Advanced Melanoma (VLA-013 MITCI)PHASE1 · COMPLETED · started May 5, 2015ClinicalTrials.gov NCT02307149 · fetched Nov 12, 2026
- CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)PHASE1 · COMPLETED · started Dec 18, 2013ClinicalTrials.gov NCT02043665 · fetched Nov 12, 2026
- CAVATAK in Patients With Stage IIIc or IV Malignant Melanoma to Extend Dosing to 48 Weeks (VLA-008 CALM Ext)PHASE2 · COMPLETED · started Jul 3, 2012ClinicalTrials.gov NCT01636882 · fetched Nov 12, 2026
- A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )PHASE2 · COMPLETED · started Dec 29, 2011ClinicalTrials.gov NCT01227551 · fetched Nov 12, 2026